C-reactive protein levels in stable COPD patients: a case-control study.

Area of Science:

• Pulmonary Medicine
• Clinical Chemistry
• Inflammation Biomarkers

Background:

• Previous research indicates elevated C-reactive protein (CRP) in stable COPD patients.
• Higher CRP levels are often associated with comorbidities like diabetes and cardiovascular disease.
• The current study investigates CRP levels in stable COPD patients without comorbidities and their association with clinical characteristics.

Purpose of the Study:

• To determine if C-reactive protein (CRP) levels are elevated in stable COPD patients compared to controls.
• To explore the association between CRP levels and pulmonary function tests (PFTs) and clinical characteristics in COPD patients.

Main Methods:

• A case-control study was conducted with 60 stable COPD patients and 30 age- and sex-matched controls.
• Participants were non-smokers.
• CRP levels and PFTs (including forced vital capacity - FVC) were measured in both groups.

Main Results:

• No significant difference in median CRP levels was observed between COPD patients (3.17 mg/L) and controls (2.13 mg/L).
• Significant positive correlation found between body mass index (BMI) and CRP (r=0.3, P=0.045) in COPD patients.
• Multivariate analysis revealed female sex and lower FVC (% of predicted) were associated with CRP levels > 3 mg/dL in COPD patients.

Conclusions:

• CRP levels are not significantly different in stable COPD patients compared to controls.
• Female sex and reduced FVC (% predicted) are associated with elevated CRP levels (> 3 mg/dL) in COPD patients.